Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384338265> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- W4384338265 abstract "Abstract Background Cystic fibrosis is an inherited disease, which is caused by the CFTR protein defects due to mutations in the CFTR gene. Along with CFTR dysfunction, exocrine pancreatic insufficiency plays a key role in persistent fat malabsorption in CF patients; therefore, deficiency of fat-soluble vitamins (A, D, E, and K) is still a therapeutic challenge. Even with efficient pancreatic enzyme medication and CF-specific vitamins, many patients with CF have fat-soluble vitamins deficiency. The present study aims to evaluate the efficiency of nanomicelle formulation of fatsoluble vitamins in children with CF in order to achieve the appropriate serum levels of these vitamins. Methods This prospective, single-blind control trial will be conducted at the Akbar Children’s Hospital in Mashhad, Iran. Patients with CF will be enrolled based on the eligibility criteria. The control group will receive the standard formulation of fat-soluble vitamins similar to the routine CF treatment and for the intervention group; the nanomicelle formulation of fat-soluble vitamins will be administrated for 3 months. The primary outcome of this study is the measurement of serum levels of fat-soluble vitamins. The secondary outcomes are clinical assessment by Shwachman-Kulczycki Score, anthropometrics, and quality of life. The outcomes will be assessed before and after 3 months. Discussion Due to the persistent fat-soluble vitamin deficiency in CF disease, the nanomicelle formulation could be proposed as a new delivery method of fat-soluble vitamins in the treatment of cystic fibrosis. Trial registration : Iranian Registry of Clinical Trials IRCT20220415054541N1. Registered on July 23, 2022." @default.
- W4384338265 created "2023-07-15" @default.
- W4384338265 creator A5033545742 @default.
- W4384338265 creator A5048139853 @default.
- W4384338265 creator A5070559029 @default.
- W4384338265 creator A5072302363 @default.
- W4384338265 creator A5076889611 @default.
- W4384338265 creator A5092471340 @default.
- W4384338265 date "2023-07-14" @default.
- W4384338265 modified "2023-09-25" @default.
- W4384338265 title "Evaluation of the Efficiency of Nanomicellar Formulation of Fat-soluble Vitamins in Patients with Cystic Fibrosis: The Study Protocol for a Randomized Controlled Trial" @default.
- W4384338265 doi "https://doi.org/10.21203/rs.3.rs-2709956/v1" @default.
- W4384338265 hasPublicationYear "2023" @default.
- W4384338265 type Work @default.
- W4384338265 citedByCount "0" @default.
- W4384338265 crossrefType "posted-content" @default.
- W4384338265 hasAuthorship W4384338265A5033545742 @default.
- W4384338265 hasAuthorship W4384338265A5048139853 @default.
- W4384338265 hasAuthorship W4384338265A5070559029 @default.
- W4384338265 hasAuthorship W4384338265A5072302363 @default.
- W4384338265 hasAuthorship W4384338265A5076889611 @default.
- W4384338265 hasAuthorship W4384338265A5092471340 @default.
- W4384338265 hasBestOaLocation W43843382651 @default.
- W4384338265 hasConcept C126322002 @default.
- W4384338265 hasConcept C168563851 @default.
- W4384338265 hasConcept C2776737053 @default.
- W4384338265 hasConcept C2776938444 @default.
- W4384338265 hasConcept C2776940978 @default.
- W4384338265 hasConcept C2777152358 @default.
- W4384338265 hasConcept C2778764654 @default.
- W4384338265 hasConcept C2780439177 @default.
- W4384338265 hasConcept C2909598748 @default.
- W4384338265 hasConcept C535046627 @default.
- W4384338265 hasConcept C61427482 @default.
- W4384338265 hasConcept C71924100 @default.
- W4384338265 hasConcept C90924648 @default.
- W4384338265 hasConceptScore W4384338265C126322002 @default.
- W4384338265 hasConceptScore W4384338265C168563851 @default.
- W4384338265 hasConceptScore W4384338265C2776737053 @default.
- W4384338265 hasConceptScore W4384338265C2776938444 @default.
- W4384338265 hasConceptScore W4384338265C2776940978 @default.
- W4384338265 hasConceptScore W4384338265C2777152358 @default.
- W4384338265 hasConceptScore W4384338265C2778764654 @default.
- W4384338265 hasConceptScore W4384338265C2780439177 @default.
- W4384338265 hasConceptScore W4384338265C2909598748 @default.
- W4384338265 hasConceptScore W4384338265C535046627 @default.
- W4384338265 hasConceptScore W4384338265C61427482 @default.
- W4384338265 hasConceptScore W4384338265C71924100 @default.
- W4384338265 hasConceptScore W4384338265C90924648 @default.
- W4384338265 hasLocation W43843382651 @default.
- W4384338265 hasOpenAccess W4384338265 @default.
- W4384338265 hasPrimaryLocation W43843382651 @default.
- W4384338265 hasRelatedWork W1973654647 @default.
- W4384338265 hasRelatedWork W1977548096 @default.
- W4384338265 hasRelatedWork W2066212396 @default.
- W4384338265 hasRelatedWork W2081490752 @default.
- W4384338265 hasRelatedWork W2161878884 @default.
- W4384338265 hasRelatedWork W2188134815 @default.
- W4384338265 hasRelatedWork W2325591522 @default.
- W4384338265 hasRelatedWork W271090126 @default.
- W4384338265 hasRelatedWork W3006823261 @default.
- W4384338265 hasRelatedWork W4384338265 @default.
- W4384338265 isParatext "false" @default.
- W4384338265 isRetracted "false" @default.
- W4384338265 workType "article" @default.